Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04076072 · ClinicalTrials.gov registry record · NA
Beveled-Tip Versus(vs) Standard-Tip Vitrectomy Probe
A NA study of Vitrectomy, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04076072: Completed NA study of Vitrectomy, sponsored by Vanderbilt University Medical Center.
NCT04076072 is a NA study of Vitrectomy that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04076072, a NA study of Vitrectomy, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the efficiency of the new Utravit High-Speed 10000 cpm Beveled Probe to the current standard vitrector probe- Alcon (non-beveled) Ultravit 7500 cpm. Study Design: This is a randomized controlled trial comparing the efficiency of the Ultravit High-Speed Beveled Probe with the current Alcon vitrector probe in a cohort of patients undergoing routine vitrectomy surgery. Hypothesis: The Advanced Ultravit high-speed beveled probe will show non-inferiority to the standard, Alcon (non-beveled) Ultravit 7500 cpm with regards to time to completion of vitrectomy and surgical outcomes.
Primary Outcome
Intraoperative efficiency of vitrectomy surgery regarding time to completion of core vitrectomy and shave of vitreous base
Conditions Studied
Interventions
- DEVICE Utravit High-Speed 10000 cpm Beveled Probe
- DEVICE standard vitrector probe- Alcon (non-beveled) Ultravit 7500 cpm
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2022-01-01 |
| Phase | NA |
What the finished NCT04076072 record still lists
NCT04076072 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Vitrectomy appearing as the primary indexed condition, and to 2 interventions - of which Utravit High-Speed 10000 cpm Beveled Probe is the first listed.
NCT04076072 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT04076072 about?
NCT04076072 is a clinical study titled "Beveled-Tip Versus(vs) Standard-Tip Vitrectomy Probe". The purpose of this study is to compare the efficiency of the new Utravit High-Speed 10000 cpm Beveled Probe to the current standard vitrector probe- Alcon (non-beveled) Ultravit 7500 cpm. Study Design: This is a randomized controlled trial comparing the efficiency of the Ultravit High-Speed Bevel...
What is the current status of trial NCT04076072?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2019-09-01. Estimated completion is 2022-01-01.
What conditions does trial NCT04076072 study?
This clinical trial studies the following conditions: Vitrectomy.
What interventions are being tested in trial NCT04076072?
The interventions under investigation include: Utravit High-Speed 10000 cpm Beveled Probe (DEVICE), standard vitrector probe- Alcon (non-beveled) Ultravit 7500 cpm (DEVICE).
Who is sponsoring clinical trial NCT04076072?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04076072 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vitrectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04076072's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI